ISRCTN51555498已完成未知
Scottish Post Menopausal Chemo-Endocrine Trial
Scottish Cancer Therapy Network (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically confirmed invasive carcinoma of the breast
- •2. Post-menopausal
- •3. Aged <70 years
- •4. No medical contraindications to treatment
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Scottish Pre-Menopausal Chemo-Endocrine TrialBreastCancerISRCTN95231655Scottish Cancer Therapy Network (UK)1,000
进行中（未招募）
不适用
The CORE Study (Chemotherapy or Endocrine Treatment first?) - COREEUCTR2005-000986-20-DETechnical University of Munich1,500
已完成
3 期
IBCSG VII - Adjuvant chemotherapy in node positive postmenopausal breast cancer patients: endocrine vs. chemo-endocrine vs. chemo-endocrine with delayed chemotherapy.Cancer - BreastBreast CancerACTRN12607000023459International Breast Cancer Study Group1,200
已完成
不适用
CHEMOTHERAPY STUDY WITH PREMENOPAUSIC ENDOCRINE RESPONSE (PERCHE), A PHASE III TRIAL EVALUATING THE ROLE OF CHEMOTHERAPY AS ADJUVANT THERAPY FOR PREMENOPAUSIC WOMEN WITH BREAST CANCER WITH ENDOCRINE RESPONSE WHO RECEIVE ENDOCRINE THERAPY.-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-070-03INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,
Enrolling By Invitation
不适用
MESI-STRAT Endocrine Therapy Termination TrialC50Malignant neoplasm of breastDRKS00014942Stiftung PATH Biobank200